Samsung Biologics
207940.KS
$559.26
Share price
-1.28%
Change (1 day)
-5.17%
Change (1 year)
Categories
Operating Margin for Samsung Biologics (207940.KS)
Operating Margin as of April 2024 (TTM): 33.94%
According to Samsung Biologics 's latest financial reports and stock price the company's current Operating Margin is 33.94%. At the end of 2022 the company had an Operating Margin of 33.62%.
Operating Margin history for Samsung Biologics from 2016 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 33.62% | -6.08% |
| 2021 | 35.80% | 56.75% |
| 2020 | 22.84% | 3.08% |
| 2019 | 22.15% | -60.82% |
| 2018 | 56.55% | -326.5% |
| 2017 | -24.97% | -68.15% |
| 2016 | -78.37% | -102.88% |
| 2015 | 2,725.81% | -2975.11% |
| 2014 | -94.81% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.